blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1043316

EP1043316 - Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.08.2003
Database last updated on 29.06.2024
Most recent event   Tooltip26.11.2004Lapse of the patent in a contracting state
New state(s): MC
published on 12.01.2005  [2005/02]
Applicant(s)For all designated states
LifeTech Pharmaceuticals Ltd
No 139 Hedong Nan Lu, Conghua
Guangdong 510925 / CN
[2003/16]
Former [2000/41]For all designated states
S & H Pharm Technology Co. Ltd
No 139 Hedong Nan Lu, Conghua
Guangdong 510925 / CN
Inventor(s)01 / Yu, Ruihong
RM. 1802, No. 410, Tianhe Bei Lu
Guangdong / CN
[2000/41]
Representative(s)Pawlyn, Anthony Neil
Murgitroyd & Company Cardiff
Churchill House
Churchill Way
Cardiff CF10 2HH / GB
[N/P]
Former [2000/41]Pawlyn, Anthony Neil
Urquhart-Dykes & Lord, Tower House, Merrion Way
Leeds, West Yorkshire LS2 8PA / GB
Application number, filing date00302870.105.04.2000
[2000/41]
Priority number, dateCN1999101612808.04.1999         Original published format: CN 99116128
[2000/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1043316
Date:11.10.2000
Language:EN
[2000/41]
Type: A3 Search report 
No.:EP1043316
Date:02.11.2000
[2000/44]
Type: B1 Patent specification 
No.:EP1043316
Date:16.10.2002
Language:EN
[2002/42]
Search report(s)(Supplementary) European search report - dispatched on:EP15.09.2000
ClassificationIPC:C07D233/94, A61K31/4168, A61P43/00
[2000/44]
CPC:
A61K41/0038 (EP,US); A61P31/00 (EP); A61P35/00 (EP);
A61P43/00 (EP); C07D233/94 (EP,US)
Former IPC [2000/41]C07D233/92, A61K31/415, A61P43/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/41]
TitleGerman:Nitroimidazolderivate als Empfindlichkeitsverstärker für Chemotherapie und Radiotherapie[2000/41]
English:Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy[2000/41]
French:Dérivés de nitroimidazole en tant que renforceur de sensibilité pour la chémothérapie et la radiothérapie[2000/41]
Examination procedure26.04.2001Examination requested  [2001/26]
22.01.2002Despatch of communication of intention to grant (Approval: Yes)
13.05.2002Communication of intention to grant the patent
25.07.2002Fee for grant paid
25.07.2002Fee for publishing/printing paid
Opposition(s)17.07.2003No opposition filed within time limit [2003/41]
Fees paidRenewal fee
29.04.2002Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipGR16.10.2002
CY05.04.2003
LU05.04.2003
IE07.04.2003
MC30.04.2003
[2005/02]
Former [2004/44]GR16.10.2002
CY05.04.2003
LU05.04.2003
IE07.04.2003
Former [2004/39]GR16.10.2002
LU05.04.2003
IE07.04.2003
Former [2004/29]GR16.10.2002
IE07.04.2003
Former [2003/45]GR16.10.2002
DE17.01.2003
Former [2003/31]GR16.10.2002
Documents cited:Search[A]WO8808840  (CENTRE NAT RECH SCIENT [FR]) [A] 1,8* claim - *;
 [A]EP0319329  (BRITISH TECH GROUP [GB]) [A] 1,8 * page 2, line 42 - line 59 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.